Disease or Syndrome – Page 150

Pfizer’s Revolutionary Hemophilia B Gene Therapy Gains FDA Approval and Introduces Unique Warranty Program

2 years ago talkbio0Tagged Approved, Biotechnology, Blood coagulation, gene therapy, Health care facility, Hemophilia B, Hereditary Diseases, Pfizer, United States Food and Drug Administration

Pfizer, FDA, Hemophilia B, Gene Therapy, Approval, Warranty, Treatment, Genetic Disorder, Blood Clotting, Healthcare, Biotechnology

Sanofi Eyes COPD Treatment as Major Growth Driver for Dupixent, Says CEO

2 years ago talkbio0Tagged Asthma, CEO, Chronic Obstructive Airway Disease, Clinical Trials, Dermatitis, Atopic, Dupixent, expansion, growth pillar, Immunology, sanofi

Sanofi, Dupixent, COPD, growth pillar, immunology, CEO, treatment, expansion, clinical trials, asthma, atopic dermatitis.

Novo Nordisk Faces Scrutiny Over High Prices of Ozempic and Wegovy

2 years ago talkbio0Tagged Diabetes, Nordisk, Obesity, Prices, Sanders, Senator Bernie, Wegovy

Novo Nordisk, Ozempic, Wegovy, drug prices, Senator Bernie Sanders, diabetes, obesity

FDA Approves Pfizer’s Hemophilia B Gene Therapy with a $3.5 Million Price Tag

2 years ago talkbio0Tagged Approved, Biotechnology, Financial cost, gene therapy, Health care facility, Hemophilia B, Hereditary Diseases, Pfizer, Pricing, United States Food and Drug Administration

Pfizer, FDA, hemophilia B, gene therapy, approval, pricing, healthcare, biotechnology, rare diseases, genetic disorders, treatment cost.

BMS Realigns Workforce Post-Mergers and Acquisitions: A Strategic Move Affecting 2,200 Employees

2 years ago talkbio0Tagged Acquisitions, Burning Mouth Syndrome, mergers, strategic, Workers

BMS, layoffs, mergers and acquisitions, workforce realignment, strategic move, 2, 200 employees

GSK Files Lawsuit Against Pfizer and BioNTech for Alleged COVID-19 Vaccine Patent Violation

2 years ago talkbio0Tagged BioNTech, COVID19 (disease), infringement, Intellectual Property, Legal patent, Pfizer, SmithKline Beecham, Vaccines

GSK, Pfizer, BioNTech, COVID-19, patent infringement, vaccine, lawsuit, intellectual property

Endo’s Par Pharmaceutical Recalls Blood Pressure Medication Due to Potential Contamination

2 years ago talkbio0Tagged adulteration, blood pressure medication, Dosage Forms, Endometriosis, Expiration, function, hydrochlorothiazide, Mental Recall, mg/12.5, Tablet Dosage Form

Endo, Par Pharmaceutical, recall, blood pressure medication, contamination, quinapril HCl/ hydrochlorothiazide tablets, USP 20 mg/12.5 mg, lot number 0KG190092, expiration date 03/2022

FDA Approves Long-Established European UTI Antibiotic by Utility Therapeutics

2 years ago talkbio0Tagged Antibiotics, European (ethnic group), Market, United States Food and Drug Administration, Urinary tract infection, UTI, year

Utility Therapeutics, FDA, UTI antibiotic, European market, 40-plus years.

Senator Sanders Investigates Skyrocketing Costs of Novo Nordisk’s Diabetes and Weight Loss Drugs

2 years ago talkbio0Tagged Affordability, Diabetes, Evaluation, Health care facility, Nordisk, Novos, Prices, Senator Bernie Sanders, Wegovy

Senator Bernie Sanders, Novo Nordisk, diabetes, weight loss, drug prices, Novos Ozempic, Wegovy, investigation, healthcare costs, affordability

FDA Greenlights UTILITY’s Innovative Antibiotic for Simple Urinary Tract Infections in Women

2 years ago talkbio0Tagged Antibiotics, Approved, United States Food and Drug Administration, Urinary tract infection, UTI, Utilities (organization), Woman

FDA, UTILITY, antibiotic, uncomplicated UTI, women, approval, innovative, treatment, urinary tract infection